The induction of spermidine/spermine N1-acetyltransferase (SSAT) is a common event in the response of human primary non-small cell lung carcinomas to exposure to the new antitumor polyamine analogue N1,N11- bis(ethyl)norspermine

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1638-1641

  Gabrielson, Edward W ^a   Pegg, Anthony E ^b   Casero Jr , Robert A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; N1,N11 DIETHYLNORSPERMINE; SPERMIDINE; SPERMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG PROTEIN BINDING; ENZYME ASSAY; ENZYME INDUCTION; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS;

ACETYLTRANSFERASES; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARCINOMA, SMALL CELL; CLINICAL TRIALS, PHASE II; ENZYME INDUCTION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHENOTYPE; POLYAMINES; SPERMINE;

EID: 0032790812     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. McCann, P. P., and Pegg, A. E. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther., 54: 195-215, 1992.
2. Marton, L. J., and Pegg, A. E. Polyamines as targets for therapeutic intervention. Ann. Rev. Pharmacol., 35: 55-91, 1995.
3. Porter, C. W., Regenass, U., and Bergeron, R. J. Polyamine inhibitors and analogues as potential anticancer agents. In: R. H. Dowling, U. R. Folsch, and C. Loser (eds.), Polyamines in the Gastrointestinal Tract, pp. 301-322. Dordrecht: Academic Publishers, 1992.
4. Casero, R. A., Ervin, S. J., Celano, P., Baylin, S. B., and Bergeron, R. J. Differential response to treatment with bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in culture. Cancer Res., 49: 639-643, 1989.
5. 1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res., 49: 3829-3833, 1989.
6. Casero, R. A., Mank, A. R., Saab, N. H., Wu, R., Dyer, W. J., and Woster, P. M. Growth and biochemical effects of asymmetrically substituted polyamine analogues in human lung tumor cells. Cancer Chemother. Pharmacol., 36: 69-74, 1995.
7. 1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res., 51: 3715-3720, 1991.
8. 11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res., 53: 581-586, 1993.
9. Chang, B. K., Bergeron, R. J., Porter, C. W., and Liang, Y. Antitumor effects of N-Alkylated polyamine analogues in human pancreatic adenocarcinoma models. Cancer Chemother. Pharmacol., 30: 179-182, 1992.
10. Bernacki, R. J., Bergeron, R. J., and Porter, C. W. Antitumor activity of N,N′-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res., 52: 2424-2430, 1992.
11. 11-diethylnorspermine administered by multiple injection or continuous infusion. Clin. Cancer Res., 1: 847-857, 1995.
12. 11 -diethylnorspermine (DENSPM) in patients with non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol. 17: 733, 1998.
13. Bergeron, R. J., Neims, A. H., McManis, J., Hawthorne, J. S., Vinson, J. R. T., Bortell, R., and Ingeno, M. J. Synthetic polyamine analogues as antineoplastics. J. Med. Chem., 31: 1183-1190, 1988.
14. Bergeron, R. J., Hawthorne, T. R., Vinson, J. R. T., Beck, D. E., Jr., and Ingeno, M. J. Role of the methylene backbone in the antiproliferative activity of polyamine analogues of L1210 cells. Cancer Res., 49: 2959-2964, 1989.
15. 1-acetyltransferase: emerging targets for rational inhibitor design. In: R. A. Casero (ed.), Molecular Biology Intelligence Unit - Polyamines: Regulation and Molecular Interaction, pp. 171-204. Austin, TX: R. G. Landes Company, 1996.
16. 1-acetyltransferase. Bioorg. Med. Chem., 4: 825-836, 1996.
17. 1-acetyltransferase (SSAT) and potential antitumor agents. J. Med. Chem., 36: 2998-3004, 1993.
18. 12-bis(ethyl)spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res., 12: 1083-1090, 1992.
19. 1-acetyltransferase super-induced in response to treatment with antitumor polyamine analogues. Cancer Res., 54: 3955-3958, 1992.
20. 12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res., 52: 5359-5363, 1992.
21. Ha, H. C., Woster, P. M., Yager, J. D., and Casero, R. A., Jr. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. USA, 94: 11557-11562, 1997.
22. 1-acetyltransferase. J. Biol. Chem., 272: 18746-18751, 1997.
23. 1-acetyltransferase. J. Biol Chem., 273: 1964-1969, 1998.
24. 1-acetyltransferase (SSAT) is associated with an increase in sensitivity to an antiturnor polyamine analogue. Clin. Cancer Res., 4: 2003-2008, 1998.
25. 1-acetyltransferase super-induced in response to treatment with antitumor polyamine analogues. Cancer Res., 54: 3955-3958, 1994.
26. 1-acetyltransferase from rat liver. Biochemistry, 21: 6152-6158, 1982.
27. 1-acetyltransferase in a human large cell lung carcinoma. Biochem. J., 270: 615-620, 1990.
28. 1-acetyltransferase-the turning point in polyamine metabolism. FASEB J., 7: 653-661, 1993.